The FDAs draft guidance on psychedelic drugs for psychiatric and substance use disorders issued as the agency began grappling with novel mechanistic treatments for addiction acknowledged the challenge of applying traditional Phase 3 frameworks to drugs that act through non-classical pathways
Of course, AG1 is not a substitute for a healthy diet, so the benefits of a supplement versus actually eating the foods and vegetables may be less apparent
Current Rapamycin research (20242025) Human trials : Testing rapamycin for age-related muscle loss, immune decline, and Alzheimers
If you or a loved one has been diagnosed with any of the following conditions after taking Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity, Saxenda, Rybelsus, or Victoza, you may be eligible to file a legal claim against the drug manufacturers, Novo Nordisk and Eli Lilly: Gastroparesis Intestinal blockage Bowel obstruction Ileus Intestinal pseudo-blockage As the landscape of GLP-1 agonist litigation evolves, including potential future claims related to NAION, Cory Watson Attorneys remains committed to advocating for patient safety and holding pharmaceutical companies accountable for the harm their products may cause
Parkinsons disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain due to aggregation of synuclein protein inside it